EC Number   |
Substrates   |
Products   |
Reversibility   |
|---|
 1.14.14.8 | 2-hydroxyphenylacetate + FADH2 + O2 |
67.8% of the activity with anthranilate |
? + FAD + H2O |
- |
? |
 1.14.14.8 | 2-hydroxyphenylacetate + FADH2 + O2 |
62.79% relative activity |
? |
- |
? |
 1.14.14.8 | 4-hydroxyphenylacetate + FADH2 + O2 |
42.7% of the activity with anthranilate |
? + FAD + H2O |
- |
? |
 1.14.14.8 | 4-hydroxyphenylacetate + FADH2 + O2 |
42.7% relative activity |
? |
- |
? |
 1.14.14.8 | anthranilate + FADH2 + O2 |
- |
3-hydroxyanthranilate + FAD + H2O |
- |
? |
 1.14.14.8 | anthranilate + FADH2 + O2 |
highest activity |
3-hydroxyanthranilate + FAD |
- |
? |
 1.14.14.8 | more |
no substrate: kynurenine, phenol, 2-nitrobenzylic acid, chlorobenzene, naphthalene, naphthol, toluene or ethylbenzene |
? |
- |
? |
 1.14.14.8 | salicylate + FADH2 + O2 |
49.6% of the activity with anthranilate |
? + FAD + H2O |
- |
? |
 1.14.14.8 | salicylate + FADH2 + O2 |
49% relative activity |
? |
- |
? |